New meta-analysis on psilocybin therapy for depression, published yesterday in the BMJ. Data looks pretty favourable, but with the usual big caveats...
bmj.com/content/385/bm…

Paper from the APA on ethical and practical implications of psychedelics in psychiatry from 2022. A section toward the end on how to interact with patients over this question which is quite thoughtfully constructed: psychiatry.org/getattachment/…

Usona Institute Announces Launch of Ph 3 Trial Investigating Psilocybin for Major Depressive Disorder

Participants will be randomised to receive a single 25 mg dose of psilocybin, 5 mg dose of psilocybin, or an inactive placebo.

businesswire.com/news/home/2024…

This history of the European Medical Society for Psycholytic Therapy by Torsten Passie made for very interesting reading. The prevailing approaches to psychedelic treatment in Europe vs. the US were so different in the 1960s-1970s. 1/5
doi.org/10.1177/205032…

At #isrp2024 , a DEA official reported that 43% of researchers who have a DEA schedule 1 license are conducting research on psychedelics. Would never have known it was that many.

We’re thrilled that Lykos Therapeutics has announced the FDA has accepted – and granted Priority Review to – the first New Drug Application for a psychedelic-assisted therapy. Congratulations to the Lykos team and collaborators who made this possible!

maps.org/2024/02/09/map…

Slides/lectures from FDA Seminar:
Advancing Psychedelic Clinical Study Design

reaganudall.org/news-and-event…

I was 24

MDMA enhances positive affective responses to social feedback - Anya K Bershad, David T Hsu, Harriet de Wit, 2024 journals.sagepub.com/doi/abs/10.117…

History in the making - this is the first 'normal' (i.e. not in a clinical trial) script written in the modern era for psychedelic assisted therapy (180mg of MDMA) by Dr Ted Cassidy in Melbourne, Australia. More details here: linkedin.com/posts/tedcassi…

National Defense Authorization Act Will Fund Psychedelic Research for Veterans With PTSD and Traumatic Brain Injuries
shroomer.com/ptsd-tbi-milit…

'The Department of Veterans Affairs will fund research on the use of psychedelic drugs like MDMA and psilocybin along with therapy to treat post-traumatic stress disorder and depression, the agency announced Friday.'

subscriber.politicopro.com/article/2024/0…

RIP MAPS PBC (2014-2023)
rebranded to Lykos Therapeutics (Lykos=wolf in Greek. h/t Phaedrus)
also, money.
(Helena.org, Steven & Alexandra Cohen Foundation, et al.)
psychedelicalpha.com/news/maps-pbc-…

Yes!!
VA to begin researching psychedelics as treatment option for veterans govexec.com/management/202… via GovExec

We are thrilled to share a momentous achievement in our mission to transform mental health care: the submission of the first-ever New Drug Application (NDA) for psychedelic therapy to the FDA!

mapsbcorp.com/news/mdma-for-…

Today MAPS has submitted
MDMA-Assisted Therapy for PTSD
to the FDA.
psychedelicalpha.com/news/breaking-…

Our Friends at UC Berkeley Center for the Science of Psychedelics have Launched a Psychedelic Clinical Trials Map

Explore the map here:
psychedelics.berkeley.edu/clinical-trial…

Video of ⁦Dr. Rosalind Watts⁩ on this weeks podcast available here : youtu.be/_0XrZxacacs?si…

It’s not just seeing suffering that's painful. It’s hurting for others while feeling unable to help.

There’s a term for that helplessness: empathic distress. Over time, it leads to burnout and withdrawal.

If you're overwhelmed and exhausted by a heavy heart, you are not alone.

Another amazing fungi discovery! Studies show that mycelium could replace the toxic fire-retardant foam that insulates many commercial buildings. Read more about it: scientificamerican.com/article/fungi-…